$75.33 -2.79 (%) Vertex Pharmaceuticals Inc - NASDAQ

Dec. 7, 2016 | 03:10 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech?

    TalkMarkets | Nov. 23, 2016 | 00:13AM EST
  2. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets | Nov. 16, 2016 | 15:30PM EST
  3. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 20:01PM EST
  4. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  5. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  6. Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates

    TalkMarkets | Oct. 26, 2016 | 14:15PM EST
  7. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron Study On Clinical Hold

    TalkMarkets | Oct. 19, 2016 | 14:27PM EST
  8. Jefferies Sees 'Attractive Buying Opportunities' In Biotech

    TalkMarkets | Oct. 18, 2016 | 10:16AM EST
  9. Piper Lays Out Reasons To Buy Vertex With Stock Near 52-Week Lows

    TalkMarkets | Oct. 17, 2016 | 12:46PM EST
  10. Biotech Stock Roundup: Alnylam Slumps On Revusiran Update, TESARO Impresses At ESMO

    TalkMarkets | Oct. 12, 2016 | 11:14AM EST
  11. Long Setups If The Tides Can Shift

    TalkMarkets | Oct. 10, 2016 | 14:50PM EST
  12. 68 Long Setups You Should Be Watching

    TalkMarkets | Oct. 3, 2016 | 15:08PM EST
  13. Morning Call For September 29, 2016

    TalkMarkets | Sep. 29, 2016 | 09:03AM EST
  14. Vertex Filing For Expanded Kalydeco Label Rejected By FDA

    IBD | Feb. 5, 2016 | 12:48PM EST
  15. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD | Jan. 11, 2016 | 19:05PM EST
  16. Vertex Receives Two EU Approvals for KALYDECO for Cystic Fibrosis

    Benzinga | Nov. 18, 2015 | 04:19AM EST
  17. Valeant Dumps Philidor, Falls

    IBD | Oct. 30, 2015 | 17:13PM EST
  18. Alexion, Vertex Steal Mo Stanley's Eyes From Gilead

    IBD | Oct. 2, 2015 | 11:42AM EST
  19. Gilead, Valeant Downgraded; IBM, Dunkin' PTs Cut

    IBD | Oct. 2, 2015 | 07:48AM EST
  20. Wall Street Wobbles as Stocks Try to Rebound

    FoxBusiness | Sep. 29, 2015 | 07:00AM EST
  21. EU panel says yes to key drugs

    IBD | Sep. 25, 2015 | 17:47PM EST
  22. 5 Key Drugs That Just Won EU Endorsements

    IBD | Sep. 25, 2015 | 14:19PM EST
  23. VERTEX PHARMA

    IBD | Jul. 29, 2015 | 17:29PM EST
  24. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 15:44PM EST
  25. Stocks Roll Higher, Trade Mixed

    IBD | Jul. 15, 2015 | 09:58AM EST
  26. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 05:52AM EST
  27. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD | Jul. 9, 2015 | 10:12AM EST
  28. Vertex's Orkambi Approved For CF, Prices On High Side

    IBD | Jul. 2, 2015 | 15:34PM EST
  29. UPDATE: Vertex Release Confirms FDA Approval of ORKAMBI

    Benzinga | Jul. 2, 2015 | 12:47PM EST
  30. Andreas Halvorsen Increases Stake in Esperion Therapeutics

    GuruFocus | Jun. 29, 2015 | 23:18PM EST
  31. Acquisitions May Fuel Gilead Sciences' Winning Ways

    IBD | Jun. 26, 2015 | 16:28PM EST
  32. Vertex Pharma Offers Data Presentations at ECFS Conference: TRAFFIC, TRANSPORT Extension Study of Lumacaftor Im Combo with Ivacaftor Showed Improvements

    Benzinga | Jun. 11, 2015 | 08:04AM EST
  33. Vertex Announces Collaboration with Parion Sciences to Develop ENaC Inhitibors in CF, Pulmonary Diseases

    Benzinga | Jun. 4, 2015 | 15:02PM EST
  34. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 14:54PM EST
  35. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 07:02AM EST
  36. Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter

    GuruFocus | May. 20, 2015 | 13:16PM EST
  37. Stocks: Quiet Open Ahead Of Fed; Dycom Rockets, Airlines Ruffled

    IBD | May. 20, 2015 | 09:42AM EST
  38. Stocks Open To Quiet Gains; Williams, Pall And Zebra Spike

    IBD | May. 13, 2015 | 09:44AM EST
  39. Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

    Benzinga | May. 12, 2015 | 20:22PM EST
  40. Panel OKs cystic fibrosis med

    IBD | May. 12, 2015 | 18:03PM EST
  41. Vertex CF Drug Orkambi Wins FDA Advisory Panel Vote

    IBD | May. 12, 2015 | 16:10PM EST
  42. Stocks Finish Lower; GoDaddy Down After Hours On Earnings

    IBD | May. 12, 2015 | 16:03PM EST
  43. FDA Advisory Panel Vote Inconclusive on Whether Vertex's Lumacaftor Contributes Positively to Orkambi's Effectiveness

    Benzinga | May. 12, 2015 | 14:30PM EST
  44. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 17:50PM EST
  45. Apple Supplier Among 3 Top Earnings Reports Tonight

    IBD | Apr. 29, 2015 | 14:09PM EST
  46. Gilead Sciences

    IBD | Apr. 21, 2015 | 17:48PM EST
  47. Short Sellers Come Back To Biotech Stocks

    Benzinga | Feb. 26, 2015 | 13:25PM EST
  48. Short Sellers Retreat From Biotech Stocks

    Benzinga | Feb. 12, 2015 | 08:23AM EST
  49. Super Bowl Stocks: Seattle's Best Vs. Boston Strong

    IBD | Jan. 31, 2015 | 08:02AM EST
  50. Baird Releases Comments After Vertex Earnings Call

    Benzinga | Jan. 29, 2015 | 15:08PM EST
Trading Center